EPIRUBICIN HCL 2MG/ML 5 ML
EPIRUBICIN HCL 2MG/ML 5 ML: A Comprehensive Overview
Epirubicin HCl 2mg/ml 5ml is a potent antineoplastic agent belonging to the anthracycline class of chemotherapy drugs.
It is primarily used in the treatment of various types of cancer.
This medication works by interfering with the growth and spread of cancer cells in the body.
Benefits of Use:
Epirubicin HCl is a crucial medication in oncology, offering significant benefits:
It is highly effective in the treatment of breast cancer, both as adjuvant therapy and for metastatic disease.
The drug is also utilized in the management of gastric cancer, ovarian cancer, lung cancer, and certain lymphomas.
It plays a vital role in slowing the progression of cancer and improving patient outcomes when used as part of a comprehensive treatment plan.
How to Use:
- Epirubicin HCl 2mg/ml 5ml is a sterile solution intended for intravenous administration only.
- It must be administered by a qualified healthcare professional experienced in the use of cytotoxic agents.
- The dosage and duration of treatment are determined by your doctor based on your specific cancer type, stage, body surface area, and overall health.
- The injection is typically given as a slow intravenous infusion, often diluted in suitable infusion solutions.
- It is crucial to follow all instructions provided by your healthcare team during and after the administration of Epirubicin.
Caution & Warnings:
- Cardiotoxicity: Epirubicin can cause severe cardiac damage, which may be irreversible. Cardiac function must be closely monitored before, during, and after treatment.
- Myelosuppression: Bone marrow suppression (decreased blood cell counts) is a dose-limiting toxicity. Regular monitoring of complete blood counts is essential.
- Extravasation: Accidental leakage of the drug outside the vein during infusion can cause severe tissue damage, necrosis, and blistering.
- Secondary Malignancies: There is an increased risk of developing secondary acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with anthracycline therapy.
- Pregnancy and Breastfeeding: Epirubicin is not recommended during pregnancy or breastfeeding due to potential harm to the fetus or infant. Effective contraception must be used by both male and female patients during and for a period after treatment.
- Liver and Kidney Impairment: Dosage adjustments may be necessary in patients with impaired liver or kidney function.
- Infections: Due to myelosuppression, patients are at a higher risk of developing serious infections.
Ingredients:
Active ingredient: Epirubicin hydrochloride 2 mg/mL.
Other ingredients typically include water for injections and may contain sodium chloride and pH adjusters.
Product Details:
Epirubicin HCl 2mg/ml is supplied as a clear, red-orange sterile solution for injection.
Each 5 mL vial contains 10 mg of Epirubicin hydrochloride.
It is for single-use only, and any unused portion must be discarded.
| Gtin | 29-355-04 |
|---|---|
| Recommended Sale Price | 54.2 |
| Is Wasfaty Product | No |
| Brand | Not Defined |
| Ingredient Name | EPIRUBICIN HYDROCHLORIDE |
| SFDA Reg. No | 29-355-04 |
| IBC | 29-355-04 |
| Drug Type | Prescription |
| Scientific Name | Epirubicin hydrochloride |
| Strength | 2 mg/mL |
| Strength Unit | mg/mL |
| Form | Solution for Injection |
| Admin Route | Intravenous |
| Size | 5 |
| Size Unit | mL |
| Package Types | Vial |
| Package Size | 5 mL |
| shelfLife | 24 months |
| Storage conditions | Store in a refrigerator (2°C to 8°C). Protect from light. |
| Refrigerator Storage | Yes |
